Implementation of new tests and treatments for patients with advanced triple negative breast cancer in routine care - data from the registry platform OPAL

被引:0
|
作者
Zahn, M. -O [1 ]
Welt, A. [2 ]
Thill, M. [3 ]
Stickeler, E. [4 ]
Zaiss, M. [5 ]
Nusch, A. [6 ]
Engel, E. [7 ]
Chiabudini, M. [8 ]
Kruggel, L. [8 ]
Jaenicke, M. [8 ]
Marschner, N. [5 ]
Woeckel, A. [9 ]
Harbeck, N. [10 ]
Decker, T. [11 ]
机构
[1] Uberortliche Berufsausubungsgemeinschaft MVZ Onko, Goslar, Germany
[2] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[3] Agaples Markus Krankenhaus, Klin Gynakol & Gynakol Onkol, Frankfurt, Germany
[4] Uniklin RWTH Aachen, Gynakol & Geburtsmed, Aachen, Germany
[5] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
[6] Praxis Hamatol & Internist Onkol, Ratingen, Germany
[7] Hamatol Onkol Praxis Altona HOPA, Hamburg, Germany
[8] IOMEDICO, Freiburg, Germany
[9] Univ Klinikum Wurzburg, Frauenklin & Poliklin, Wurzburg, Germany
[10] Klinikum Univ Munchen, Frauenklin, Brustzentrum Innenstadt, Munich, Germany
[11] Studienzentrum Onkol Ravensburg Prof Dr Dechow, Dr Nonnenbroich GbR, Ravensburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ep110
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [21] Building momentum for subsets of patients with advanced triple-negative breast cancer
    Woodward, Wendy A.
    LANCET ONCOLOGY, 2020, 21 (01): : 3 - 5
  • [22] New treatment strategies for patients with triple-negative breast cancer
    Liedtke, Cornelia
    Rody, Achim
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2015, 27 (01) : 77 - 84
  • [23] Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
    Mancini, Patrizia
    Angeloni, Antonio
    Risi, Emanuela
    Orsi, Errico
    Mezi, Silvia
    CANCERS, 2014, 6 (04) : 2187 - 2223
  • [24] Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry
    Hartkopf, Andreas D.
    Huober, Jens
    Volz, Bernhard
    Nabieva, Naiba
    Taran, Florin-Andrei
    Schwitulla, Judith
    Overkamp, Friedrich
    Kolberg, Hans-Christian
    Hadji, Peyman
    Tesch, Hans
    Haeberle, Lothar
    Ettl, Johannes
    Lux, Michael P.
    Lueftner, Diana
    Wallwiener, Markus
    Mueller, Volkmar
    Beckmann, Matthias W.
    Belleville, Erik
    Wimberger, Pauline
    Hielscher, Carsten
    Geberth, Matthias
    Fersis, Nikos
    Abenhardt, Wolfgang
    Kurbacher, Christian
    Wuerstlein, Rachel
    Thomssen, Christoph
    Untch, Michael
    Fasching, Peter A.
    Janni, Wolfgang
    Fehm, Tanja N.
    Wallwiener, Diethelm
    Brucker, Sara Y.
    Schneeweiss, Andreas
    BREAST, 2018, 37 : 42 - 51
  • [25] Cancer-Related Distress and Unmet Needs Among Triple Negative Breast Cancer Patients: Findings from the Cancer Experience Registry
    Lawrence, Caroline
    Fortune, Erica E.
    Badt, Heather
    Doughtie, Kara
    Popalis, Madyson L.
    Miller, Melissa F.
    CANCER RESEARCH, 2023, 83 (05)
  • [26] Is Taxane Rechallenge Time Dependent in Patients With Advanced Triple-Negative Breast Cancer?
    Altundag, Kadri
    CLINICAL BREAST CANCER, 2023, 23 (03) : E55 - E55
  • [27] Geicam/2014-03 (registem): A prospective registry of advanced breast cancer: A subset of triple negative breast cancer patients with her2 low expression
    Jara, Carlos
    Alvarez, Isabel
    Rodriguez, Cesar A.
    Martinez, Purificacion
    Andres, Raquel
    Rodriguez-Lescure, Alvaro
    Malon, Diego
    Luis Alonso, Jose
    Adrover, Encarna
    Jose Echarri, Maria
    Margeli, Mireia
    Tibau, Ariadna
    Ramirez, Judith
    Antolin, Silvia
    Campo, Ruth
    Jose Miralles, Juan
    Bezares, Susana
    Rojo, Federico
    Lopez-Tarruella, Sara
    Guerrero-Zotano, Angel
    CANCER RESEARCH, 2021, 81 (04)
  • [28] An electronic data registry for evaluating fulvestrant treatment in patients with advanced breast cancer
    Wade, JL
    Esparaz, BT
    Lower, EE
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S80 - S80
  • [29] COMPARATIVE EFFECTIVENESS OF TREATMENTS FOR ADVANCED OR METASTATIC TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Yadav, N.
    VALUE IN HEALTH, 2022, 25 (01) : S30 - S30
  • [30] Recommendation of the AGO Breast Committee for Triple-Negative Breast Cancer - Real World Data on Implementation and Adherence
    Jackisch, Christian
    Janni, Wolfgang
    Mueller, Volkmar
    Schilling, Joerg
    Lindenmaier, Patrik
    Jaeger, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 21 - 21